 Home > Drugs > Dextran 40

Dextran 40

Indication

Suitable for hypovolemic shock and thromboembolic diseases.

Shock

Manufacturer

Gansu Changee Bio-Pharmaceutical Co., Ltd.

Founded in:

2005-08-05
Address:

Tianshui Erpu Industrial Demonstration Zone
Tax NO.:

916205007734444550
Registered Funds:

229.09 million yuan
Website:

Log in to view
Email:

Log in to view

Other Drugs of Gansu Changee Bio-Pharmaceutical Co., Ltd.

Acetazolamide Tablets Gastric flat film Compound Toin Ephedrine and Theophylline Tablets Compound sulfadiazine tablets Glucose Sodium Chloride Potassium Injection Glucose Sodium Chloride Potassium Injection



Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
(We`ll never share your email address with a third-party.)

National-level Technology-based SME
China's Top 100 Industrial Digitalization Enterprises List
The Drafting Unit of the "Specification for Operation and Management of Self-build Cross-border E-commerce Website" of the CCPIT
High-Tech Enterprise

鲁ICP备16009155号-1 | Copyright@Qingdao ECHEMI Digital Technology Co., Ltd.



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.